Open access · OA
via OpenAlex
Clinicopathological Staging of Dynamics of Neurodegeneration and Neuronal Loss in Alzheimer Disease
Jerzy Węgiel, Michael J. Flory, Izabela Kuchna, Krzysztof Nowicki, Shuang Yong Ma, Jarek Wegiel, Eulalia Badmajew, Mony J. de Leon, Thomas Wısnıewskı, Barry Reisberg
Journal of Neuropathology & Experimental Neurology · 2020 · ▲ 19 citations
Abstract
Clinical and neuropathological staging of Alzheimer disease (AD) neurodegeneration and neuronal loss dynamics is the baseline for identification of treatment targets and timing. The aim of this study of 14 brain regions in 25 subjects diagnosed with AD and 13 age-matched control subjects was to establish the pattern of neurodegeneration, and the severity and rate of neuronal loss in mild cognitive impairment/mild AD (Functional Assessment Staging [FAST] test 3-4), moderate to moderately severe AD (FAST 5-6), and severe AD (FAST 7). The study revealed (1) the most severe neuronal loss in FAST 3-4; (2) the highest rate of neuronal loss in FAST 5-6, to the "critical" point limiting further increase in neuronal loss; (3) progression of neurofibrillary degeneration, but decline of neuronal loss to a floor level in FAST 7; and (4) structure-specific rate of neuronal loss caused by neurofibrillary degeneration and a large pool of neuronal loss caused by other mechanisms. This study defines a range and speed of progression of AD pathology and functional decline that might potentially be prevented by the arrest of neuronal loss, both related and unrelated to neurofibrillary degeneration, during the 9-year duration of mild cognitive impairment/mild AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/jnen/nlaa140
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Węgiel, J., Flory, M.J., Kuchna, I., Nowicki, K., Ma, S.Y., Wegiel, J., Badmajew, E., Leon, M.J.D., Wısnıewskı, T., & Reisberg, B. (2020). Clinicopathological Staging of Dynamics of Neurodegeneration and Neuronal Loss in Alzheimer Disease. <em>Journal of Neuropathology & Experimental Neurology</em>. https://doi.org/10.1093/jnen/nlaa140
Vancouver
Węgiel J, Flory MJ, Kuchna I, Nowicki K, Ma SY, Wegiel J, et al. Clinicopathological Staging of Dynamics of Neurodegeneration and Neuronal Loss in Alzheimer Disease. Journal of Neuropathology & Experimental Neurology. 2020. doi:10.1093/jnen/nlaa140.
BibTeX
@article{jerzy2020Clinic,
title = {Clinicopathological Staging of Dynamics of Neurodegeneration and Neuronal Loss in Alzheimer Disease},
author = {Jerzy Węgiel and Michael J. Flory and Izabela Kuchna and Krzysztof Nowicki and Shuang Yong Ma and Jarek Wegiel and Eulalia Badmajew and Mony J. de Leon and Thomas Wısnıewskı and Barry Reisberg},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2020},
doi = {10.1093/jnen/nlaa140},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Eisai Co., Ltd. 2010
Open access · US-GOV
Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
University of Oviedo 2022
Open access · US-GOV
Relationship Between Frailty and Cognitive Impairment in Patients With Parkinson's Disease or Secondary Parkinsonism.
Acta Neuropathologica Communications 2022
Open access · CC-BY
Developmental deficits and staging of dynamics of age associated Alzheimer’s disease neurodegeneration and neuronal loss in subjects with Down syndrome
National Institute on Aging (NIA) 1999
Open access · US-GOV
A Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin E and Donepezil HCL (Aricept) to Delay Clinical Progression From Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD)
Aging Brain 2022
Open access · CC-BY
Compromised autophagy and mitophagy in brain ageing and Alzheimer’s diseases
Chinese PLA General Hospital 2025
Open access · US-GOV